leadf
logo-loader
viewInnoCan Pharma

Innocan Pharma launches Derma CBD line in Europe

Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has launched their CBD derma line. Bincovich discusses where it is being made and the first areas of the world it is being rolled out to.

Bincovich also told gave Proactive an update on their Pharma work and how their capital raise is going.

Quick facts: InnoCan Pharma

Price: 0.175 CAD

CSE:INNO
Market: CSE
Market Cap: $30.68 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of InnoCan Pharma named herein, including the promotion by the Company of InnoCan Pharma in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Innocan Pharma teams up with Endless Sky to manufacturer and distribute its...

Innocan Pharma Corporation (CSE:INNO) CEO Iris Bincovich and Endless Sky CEO Travis George tells Proactive the two have signed a manufacturing and distribution agreement. Bincovich says Endless Sky will exclusively distribute Innocan’s CBD products in Canada and manufacture them at its Health...

on 18/8/20

2 min read